While therapies directly targeting adipogenesis remain rare and more effective targets for obesity and metabolic disease are likely to exist, the role of RFP in balancing adipose and skeletal muscle metabolism presents a compelling mechanism of scientific interest. The gene discussed is TRIM27; the disease is Other metabolic disease.